# Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.

> **NCT00141089** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 1026 (—)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** Tegaserod

## Key facts

- **NCT ID:** NCT00141089
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 1026 (—)
- **Last updated:** 2008-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141089, "Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00141089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*